HTFL
Heartflow, Inc.26.47
+0.84+3.28%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
2.25BP/E (TTM)
-Basic EPS (TTM)
-1.50Dividend Yield
0%Recent Filings
10-K
8-K
8-K
HeartFlow posts investor deck
HeartFlow posted its January 2026 investor presentation under Item 7.01, highlighting $162MM LTM 3Q25 revenue with 41% YoY FFRCT base growth and 76% non-GAAP gross margin. U.S. installed base hit 1,465 accounts; Plaque reached 489 sites with Category 1 CPT reimbursement from Jan 1, 2026. Plaque accelerates monetization of 66% untapped CCTAs.
8-K
Q3 revenue jumps 41%
Heartflow crushed Q3 2025 with $46.3M revenue, up 41% year-over-year, fueled by U.S. FFRCT growth and fresh coverage from UnitedHealthcare and Cigna for Plaque Analysis. Gross margins ticked to 76.5%; non-GAAP net loss narrowed to $11.1M. Cash swelled to $291.2M post-IPO. Full-year revenue guide: $173.0M-$173.5M. Warrants fully exercised.
10-Q
Q3 FY2025 results
Heartflow's Q3 revenue jumped 41% y/y to $46.3M from $32.9M, with gross margin edging up to 77% from 76% amid higher case volumes. Operating loss held steady at $15.1M despite R&D and SG&A growth, but net loss widened to $50.9M from $19.1M due to $32.1M warrant liability fair-value hit and $6.4M debt extinguishment—net exceeded operating by >20% from those items. Cash swelled to $291.2M post-IPO after repaying term loan; operating cash burn eased to $43.4M YTD (derived). Debt-free now. DOJ probe into sales practices adds uncertainty.
IPO
Website
Employees
Sector
Industry
AIFF
Firefly Neuroscience, Inc.
1.41-0.06
AVR
Anteris Technologies Global Cor
4.95+0.22
BEAT
Heartbeam, Inc.
3.44+0.81
BFLY
Butterfly Network, Inc.
3.34+0.12
EW
Edwards Lifesciences Corporatio
85.32+1.94
HSCS
HeartSciences Inc.
2.31-0.16
HTCR
Heartcore Enterprises, Inc.
0.38+0.01
HYDTF
Hydreight Technologies Inc
3.10-0.06
NGHLF
Nightingale Health Oyj
1.75+0.00
OHCFF
LIGHT AI INC.
0.11+0.00